Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. u s infusion, inc.
WARNING LETTER
•u s infusion, inc. •September 17, 2014

u s infusion, inc. – FDA Warning Letter, Sep 17, 2014

Record Details

An FDA inspection of US Infusion, Inc. dba Trucare Biomedix-USA in September 2014 revealed significant violations of the Quality System regulation (21 CFR Part 820) for their Class II IV administration sets, deeming them adulterated. The firm also imports Class I IV poles and Class II syringes.

Key violations include: 1. **Purchasing Controls (21 CFR 820.50):** Failure to establish adequate procedures to ensure purchased products and services conform to requirements, including supplier quality control, personnel qualification, process validation, and equipment maintenance. The firm's procedures did not require obtaining essential documentation from future suppliers, and there was uncertainty regarding sterilization methods. Discrepancies were noted between website claims of quarterly supplier audits and actual practice. 2. **Quality Audits (21 CFR 820.22):** Failure to establish procedures for and conduct quality audits, lacking a documented schedule, specific criteria, and completed internal audits. 3. **Corrective and Preventive Action (CAPA) (21 CFR 820.100(a)):** CAPA procedures were inadequate, lacking requirements for verification/validation of effectiveness, definitions of preventive actions, and the use of statistical methodology for recurring problems. 4. **CAPA Documentation (21 CFR 820.100(b)):** Inadequate documentation of CAPA

Company
u s infusion, inc.
Inspection date
September 17, 2014
Product type
Devices
Office
Florida District Office
Person
  • Elizabeth W. Ormond
View Company Profile

ID · 8507ee58-62a0-416a-a9bb-fbfa61a33ac5

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.5021 CFR 820.2221 CFR 820.100(a)21 CFR 820.100(a)(1)21 CFR 820.100(b)21 CFR 820.30(g)21 CFR 820.30(i)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore u s infusion, inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.